earnings
NASDAQ · AVIR
Atea Pharmaceuticals, Inc.
Healthcare · Biotechnology
$5.51
Down-$0.06 (-1.09%)
Updated Aug 27, 2026, 5:55 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 250M
- P/E ratio
- -1.97
- Dividend yield
- 0.00%
- 52-week range
- $2.78 – $6.45
- Volume
- 214.11K
- Avg. volume
- 399.61K
Price performance
AVIR price history
1M range · 21 trading sessions · Daily adjusted prices
AVIR closed at $5.51 after 21 trading sessions, up 19.26% for the selected period.
- Last close
- $5.51
- Period change
- +19.26%
- Period low
- $4.61
- Period high
- $5.59
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | $5.43 | $5.59 | $5.30 | $5.51 | 214.11K |
| Aug 25, 2026 | $5.51 | $5.62 | $5.39 | $5.43 | 198.06K |
| Aug 24, 2026 | $5.385 | $5.53 | $5.25 | $5.51 | 100.1K |
| Aug 21, 2026 | $5.40 | $5.64 | $5.31 | $5.43 | 209.89K |
| Aug 20, 2026 | $5.52 | $5.545 | $5.35 | $5.36 | 214.28K |
| Aug 19, 2026 | $5.39 | $5.61 | $5.355 | $5.59 | 339.75K |
| Aug 18, 2026 | $5.22 | $5.30 | $5.1361 | $5.28 | 133.08K |
| Aug 17, 2026 | $5.11 | $5.305 | $5.05 | $5.22 | 233.58K |
| Aug 14, 2026 | $5.03 | $5.23 | $4.99 | $5.12 | 250.01K |
| Aug 13, 2026 | $5.21 | $5.55 | $4.99 | $5.07 | 669.44K |
| Aug 12, 2026 | $5.04 | $5.16 | $4.98 | $5.06 | 292.19K |
| Aug 11, 2026 | $5.05 | $5.07 | $4.92 | $5.05 | 178.47K |
| Aug 10, 2026 | $5.21 | $5.29 | $5.01 | $5.02 | 123.65K |
| Aug 7, 2026 | $4.97 | $5.30 | $4.97 | $5.25 | 264.99K |
| Aug 6, 2026 | $4.77 | $5.02 | $4.76 | $4.99 | 245.33K |
| Aug 5, 2026 | $4.71 | $4.86 | $4.68 | $4.75 | 258.84K |
| Aug 4, 2026 | $4.61 | $4.72 | $4.5494 | $4.70 | 406.39K |
| Aug 3, 2026 | $4.73 | $4.73 | $4.60 | $4.61 | 230.13K |
| Jul 31, 2026 | $4.74 | $4.98 | $4.69 | $4.70 | 471.93K |
| Jul 30, 2026 | $4.60 | $4.95 | $4.53 | $4.74 | 563.4K |
| Jul 29, 2026 | $4.42 | $4.75 | $4.4101 | $4.62 | 742.32K |
Latest AVIR news
The latest Smart Investors Daily articles mentioning AVIR.
Stock researchCompany · Financials
Loading stock research…